Nai-Jung Chiang Selected Research

Nai-Jung Chiang Research Topics

Disease

12	Neoplasms (Cancer) 06/2022 - 01/2013
10	Adenocarcinoma 06/2022 - 07/2016
8	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 07/2016
4	Disease Progression 01/2022 - 10/2015
4	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 01/2020
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021 - 01/2016
3	Esophageal Squamous Cell Carcinoma 01/2021 - 01/2020
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2014 - 01/2013
2	Cholangiocarcinoma 10/2022 - 01/2020
2	Carcinogenesis 01/2021 - 10/2015
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 06/2019
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Splenomegaly 01/2022
1	Malnutrition (Nutritional Deficiencies) 01/2022
1	Hemorrhage 01/2021
1	Fistula 01/2021
1	Esophageal Fistula 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Neutropenia 10/2020
1	Obesity 05/2020
1	Pericardial Effusion 02/2020
1	Lymphedema (Milroy Disease) 01/2020
1	Circulating Neoplastic Cells 01/2020
1	Thrombosis (Thrombus) 06/2019
1	Bile Duct Neoplasms (Bile Duct Cancer) 01/2017
1	Melanoma (Melanoma, Malignant) 10/2015
1	Necrosis 11/2014
1	Glioma (Gliomas) 10/2014
1	Glioblastoma (Glioblastoma Multiforme) 10/2014

Drug/Important Bio-Agent (IBA)

10	Gemcitabine FDA Link 01/2022 - 01/2016
9	Irinotecan (Camptosar)FDA LinkGeneric 06/2022 - 07/2016
9	Leucovorin (Folinic Acid)FDA Link 06/2022 - 11/2016
7	Fluorouracil (Carac)FDA LinkGeneric 06/2022 - 11/2016
4	Imatinib Mesylate (Gleevec)FDA Link 10/2015 - 01/2013
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2016
3	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 07/2021 - 10/2014
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2013
1	folfirinoxIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	AlbuminsIBA 01/2022
1	AntigensIBA 01/2022
1	CarbohydratesIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Prealbumin (Transthyretin)IBA 01/2022
1	Transferrin (beta 2 Transferrin)IBA 01/2022
1	Retinaldehyde (Retinal)IBA 07/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	FluoridesIBA 01/2021
1	pyrimidineIBA 01/2021
1	pembrolizumabIBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	ADI PEG20IBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 10/2020
1	Epithelial Cell Adhesion MoleculeIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	GlycosaminoglycansIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Liposomes (Liposome)IBA 11/2016
1	Cetuximab (Erbitux)FDA Link 01/2016
1	MicroRNAs (MicroRNA)IBA 10/2015
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2015
1	Histones (Histone)IBA 10/2015
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2014
1	Sirolimus (Rapamycin)FDA Link 11/2014
1	tanespimycin (17AAG)IBA 10/2014
1	Antineoplastic Agents (Antineoplastics)IBA 10/2014
1	AminesIBA 10/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2014
1	6- chloro- 9- (4- methoxy- 3,5- dimethylpyridin- 2- ylmethyl)- 9H- purin- 2- ylamineIBA 10/2014
1	5- amino- 6- methoxy- 2- (3',4',5'- trimethoxybenzoyl)quinolineIBA 01/2013

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
6	Therapeutics 01/2021 - 10/2015
4	Chemoradiotherapy 01/2022 - 01/2020
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021 - 02/2020
2	Induction Chemotherapy 01/2022 - 01/2022
2	Radiotherapy 01/2020 - 06/2019
1	Immunotherapy 10/2022
1	Neoadjuvant Therapy 01/2022
1	Time-to-Treatment 01/2022
1	Precision Medicine 01/2021
1	Drug Tapering 01/2021
1	Conservative Treatment 01/2021
1	Oral Hygiene (Dental Hygiene) 05/2020